ArticleAmerican journal of cancer research2023

Multicenter phase 2 study of intrapleural nivolumab in patients with metastatic non-small cell lung cancer and pleural effusion.

Ilya Tsimafeyeu et al.PubMed ↗Full text ↗

No numbers read from the abstract.